COVID-19
Showing NaN - NaN of 84
COVID-19 Trial in Brownsville, Houston, Tyler (Multi-Level Multi-Component Intervention (MLI), Community Just-In-Time Adaptive
Active, not recruiting
- COVID-19
- Multi-Level Multi-Component Intervention (MLI)
- Community Just-In-Time Adaptive Intervention (Community JITAI)
-
Brownsville, Texas
- +2 more
Nov 3, 2022
COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)
Terminated
- COVID-19
- Convalescent Plasma
- Masked Saline Placebo
-
Birmingham, Alabama
- +23 more
Sep 9, 2022
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
COVID-19 Trial in Worldwide (SARS-CoV-2 mRNA vaccine formulation 1, SARS-CoV-2 mRNA vaccine formulation 2, SARS-CoV-2 mRNA
Terminated
- COVID-19
- SARS-CoV-2 mRNA vaccine formulation 1
- +3 more
-
Rolling Hills Estates, California
- +20 more
Aug 22, 2022
COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)
Recruiting
- COVID-19
- Ad26.COV2.S
- +4 more
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
Intensive Care Survivors of Coronavirus Disease (COVID-19)
Recruiting
- COVID-19
-
Baltimore, Maryland
- +1 more
Aug 8, 2022
COVID-19, Long COVID, Pulmonary Fibrosis Trial in Aurora, New York, Houston (BIO 300 Oral Suspension, Placebo)
Recruiting
- COVID-19
- +4 more
- BIO 300 Oral Suspension
- Placebo
-
Aurora, Colorado
- +3 more
Aug 1, 2022
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19 Outcome Prediction Algorithm
Active, not recruiting
- COVID-19
- +4 more
- Blood and nasal swab sampling
-
Los Angeles, California
- +6 more
Jul 20, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
COVID-19, Viral Respiratory Illnesses Trial in United States (Nitazoxanide, Placebo, Vitamin Super B-Complex)
Terminated
- COVID-19
- Viral Respiratory Illnesses
- Nitazoxanide
- +2 more
-
Kissimmee, Florida
- +3 more
Jun 28, 2022
COVID-19, Muscle Weakness, Muscle Pain Trial in Houston (Electrical Stimulation - Active, Electrical Stimulation - Placebo)
Recruiting
- COVID-19
- +3 more
- Electrical Stimulation - Active
- Electrical Stimulation - Placebo
-
Houston, Texas
- +1 more
Jun 23, 2022
COVID-19 Trial in Worldwide (Dapagliflozin 10 milligram (mg), Placebo)
Completed
- COVID-19
- Dapagliflozin 10 milligram (mg)
- Placebo
-
Fairhope, Alabama
- +94 more
May 13, 2022
Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)
Recruiting
- Lower Respiratory Tract Infection
- +3 more
- DAS181
- +3 more
-
Duarte, California
- +59 more
Jun 3, 2022